Marginal structural model
Marginal structural models are a class of statistical models used for causal inference in epidemiology.[1][2] Such models handle the issue of time-dependent confounding in evaluation of the efficacy of interventions by inverse probability weighting for receipt of treatment, they allow us to estimate the average causal effects. For instance, in the study of the effect of zidovudine in AIDS-related mortality, CD4 lymphocyte is used both for treatment indication, is influenced by treatment, and affects survival. Time-dependent confounders are typically highly prognostic of health outcomes and applied in dosing or indication for certain therapies, such as body weight or lab values such as alanine aminotransferase or bilirubin.[citation needed]
The first marginal structural models were introduced in 2000. The works of James Robins, Babette Brumback, and Miguel Hernán provided an intuitive theory and an easy-to-implement software which made them popular for the analysis of longitudinal data.[3]
References
- ↑ Robins, James; Hernán, Miguel; Brumback, Babette (September 2000). "Marginal Structural Models and Causal Inference in Epidemiology". Epidemiology 11 (5): 550–60. doi:10.1097/00001648-200009000-00011. PMID 10955408. http://epiresearch.org/wp-content/uploads/2014/07/Robins_EPI_2000_11_550.pdf.
- ↑ Hernán, Miguel Ángel; Brumback, Babette; Robins, James M. (2000). "Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men". Epidemiology 11 (5): 561–570. doi:10.1097/00001648-200009000-00012. ISSN 1044-3983. PMID 10955409.
- ↑ Shinozaki, Tomohiro; Suzuki, Etsuji (September 5, 2020). "Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips" (pdf). Journal of Epidemiology 30 (9): 377–389. doi:10.2188/jea.JE20200226. ISSN 0917-5040. OCLC 8668235349. PMID 32684529. PMC 7429147. https://www.jstage.jst.go.jp/article/jea/30/9/30_JE20200226/_article. Retrieved May 27, 2021.
 |  |
